schrodinger inc - SDGR

SDGR

Close Chg Chg %
11.55 0.03 0.26%

Open Market

11.58

+0.03 (0.26%)

Volume: 781.73K

Last Updated:

Apr 2, 2026, 4:00 PM EDT

Company Overview: schrodinger inc - SDGR

SDGR Key Data

Open

$11.23

Day Range

11.16 - 11.73

52 Week Range

10.95 - 27.63

Market Cap

$854.89M

Shares Outstanding

73.83M

Public Float

62.85M

Beta

1.62

Rev. Per Employee

N/A

P/E Ratio

N/A

EPS

-$1.41

Yield

0.00%

Dividend

N/A

EX-DIVIDEND DATE

SHORT INTEREST

N/A

AVERAGE VOLUME

1.07M

 

SDGR Performance

1 Week
 
4.51%
 
1 Month
 
-9.11%
 
3 Months
 
-35.60%
 
1 Year
 
-35.77%
 
5 Years
 
-85.25%
 

SDGR Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 8
Full Ratings ➔

About schrodinger inc - SDGR

Schrödinger, Inc. engages in the provision of chemical simulation software solutions to pharmaceutical industry. It operates through the Software and Drug Discovery business segments. The Software segment sells software to transform drug discovery across the life sciences industry and to customers in materials science industries. The Drug Discovery segment offers diverse portfolio of preclinical and clinical programs, internally and through collaborations, that have advanced to various stages of discovery and development. The company was founded by Richard A. Friesner, William A. Goddard, III and Murco Ringnalda in 1990 and is headquartered in New York, NY.

SDGR At a Glance

Schrödinger, Inc.
1540 Broadway
New York, New York 10036-4041
Phone 1-212-295-5800 Revenue 255.87M
Industry Packaged Software Net Income -103,265,000.00
Sector Technology Services 2025 Sales Growth 23.287%
Fiscal Year-end 12 / 2026 Employees 850
View SEC Filings

SDGR Valuation

P/E Current N/A
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) N/A
Price to Sales Ratio 5.132
Price to Book Ratio 3.619
Price to Cash Flow Ratio 94.48
Enterprise Value to EBITDA -6.341
Enterprise Value to Sales 3.987
Total Debt to Enterprise Value 0.107

SDGR Efficiency

Revenue/Employee 301,022.353
Income Per Employee -121,488.235
Receivables Turnover 2.451
Total Asset Turnover 0.33

SDGR Liquidity

Current Ratio 2.745
Quick Ratio 2.745
Cash Ratio 2.127

SDGR Profitability

Gross Margin 55.737
Operating Margin -65.227
Pretax Margin -39.992
Net Margin -40.359
Return on Assets -13.33
Return on Equity -26.293
Return on Total Capital -21.819
Return on Invested Capital -21.088

SDGR Capital Structure

Total Debt to Total Equity 30.003
Total Debt to Total Capital 23.079
Total Debt to Total Assets 15.042
Long-Term Debt to Equity 25.495
Long-Term Debt to Total Capital 19.611
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Schrodinger Inc - SDGR

Collapse All in section
All values USD millions. 2022 2023 2024 2025 5-year trend
Sales/Revenue
180.96M 216.67M 207.54M 255.87M
Sales Growth
+31.19% +19.73% -4.21% +23.29%
Cost of Goods Sold (COGS) incl D&A
80.45M 76.56M 75.46M 113.25M
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
4.34M 5.55M 6.16M 6.02M
Depreciation
3.83M 4.96M 6.16M 6.02M
Amortization of Intangibles
- - 513.00K 587.00K
-
COGS Growth
+8.27% -4.83% -1.44% +50.09%
Gross Income
100.51M 140.10M 132.08M 142.61M
Gross Income Growth
+57.96% +39.40% -5.73% +7.97%
Gross Profit Margin
+55.54% +64.66% +63.64% +55.74%
2022 2023 2024 2025 5-year trend
SG&A Expense
247.33M 317.55M 341.38M 309.51M
Research & Development
126.37M 181.77M 201.78M 173.14M
Other SG&A
120.95M 135.79M 139.59M 136.37M
SGA Growth
+41.27% +28.39% +7.50% -9.34%
Other Operating Expense
- - - -
-
Unusual Expense
18.08M (53.46M) (5.68M) (48.17M)
EBIT after Unusual Expense
(164.90M) (123.99M) (203.61M) (118.72M)
Non Operating Income/Expense
15.78M 166.91M 17.90M 16.40M
Non-Operating Interest Income
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
- - - -
-
Interest Expense Growth
- - - -
-
Gross Interest Expense
- - - -
-
Interest Capitalized
- - - -
-
Pretax Income
(149.13M) 42.92M (185.71M) (102.33M)
Pretax Income Growth
-47.93% +128.78% -532.70% +44.90%
Pretax Margin
-82.41% +19.81% -89.48% -39.99%
Income Tax
63.00K 2.20M 1.41M 939.00K
Income Tax - Current - Domestic
(475.00K) 1.24M 150.00K 316.00K
Income Tax - Current - Foreign
538.00K 963.00K 1.51M 1.24M
Income Tax - Deferred - Domestic
- - - -
-
Income Tax - Deferred - Foreign
- - (253.00K) (614.00K)
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
(149.19M) 40.72M (187.12M) (103.27M)
Minority Interest Expense
- - - (3.00K)
-
Net Income
(149.19M) 40.72M (187.12M) (103.27M)
Net Income Growth
-48.60% +127.29% -559.54% +44.81%
Net Margin Growth
-82.44% +18.79% -90.16% -40.36%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
(149.19M) 40.72M (187.12M) (103.27M)
Preferred Dividends
- - - -
-
Net Income Available to Common
(149.19M) 40.72M (187.12M) (103.27M)
EPS (Basic)
-2.0961 0.5673 -2.575 -1.406
EPS (Basic) Growth
-47.39% +127.06% -553.90% +45.40%
Basic Shares Outstanding
71.17M 71.78M 72.67M 73.44M
EPS (Diluted)
-2.0961 0.543 -2.575 -1.406
EPS (Diluted) Growth
-47.39% +125.91% -574.22% +45.40%
Diluted Shares Outstanding
71.17M 74.99M 72.67M 73.44M
EBITDA
(142.47M) (171.90M) (203.14M) (160.87M)
EBITDA Growth
-31.20% -20.65% -18.17% +20.81%
EBITDA Margin
-78.73% -79.34% -97.88% -62.87%

Snapshot

Average Recommendation OVERWEIGHT Average Target Price 23.111
Number of Ratings 8 Current Quarters Estimate -0.602
FY Report Date 06 / 2026 Current Year's Estimate -2.121
Last Quarter’s Earnings -0.59 Median PE on CY Estimate N/A
Year Ago Earnings -1.41 Next Fiscal Year Estimate -1.478
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 5 6 7 7
Mean Estimate -0.60 -0.56 -2.12 -1.48
High Estimates -0.53 -0.32 -1.89 -0.56
Low Estimate -0.71 -0.68 -2.42 -1.91
Coefficient of Variance -13.34 -24.34 -9.27 -32.51

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 6 7 7
OVERWEIGHT 0 0 0
HOLD 2 2 3
UNDERWEIGHT 0 0 0
SELL 0 0 0
MEAN Overweight Buy Overweight

Schrodinger Inc in the News